Amia Capital LLP Vertex Pharmaceuticals Inc Transaction History

Amia Capital LLP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 11, 2021	SELL	$207.01 - $276.09 $1.04 Million - $1.39 Million	-5,026 Closed	0 $0
Q3 2020 Nov 16, 2020	SELL	$255.65 - $303.1 $594,386 - $704,707	-2,325 Reduced 31.63%	5,026 $1.37 Million
Q2 2020 Aug 14, 2020	SELL	$225.48 - $295.8 $779,709 - $1.02 Million	-3,458 Reduced 31.99%	7,351 $2.13 Million
Q1 2020 May 15, 2020	SELL	$199.77 - $247.81 $716,774 - $889,142	-3,588 Reduced 24.92%	10,809 $2.57 Million
Q4 2019 Feb 13, 2020	BUY	$166.71 - $223.91 $2.4 Million - $3.22 Million	14,397 New	14,397 $3.15 Million

1,707

226M

1.2M

1.59M

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $120B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

Get notified when there are updates to the investment portfolio of Amia Capital LLP, based on Form 13F filings with the SEC.

Stay updated on Amia Capital LLP with notifications on news.